You are here

Overview of Resources for NIH - Other Support and Biosketches

January 25, 2022

NIH National Institutes of HealthU-M research investigators need to follow new requirements when submitting Other Support Reporting and Biographical Sketches (Biosketches) for proposals, Just-In-Time (JIT) materials, or Research Performance Progress Reports (RPPRs) to the National Institutes of Health (NIH).  These changes may require additional time on your part, and these links and resources are meant to assist you.

  • For transparency and to avoid scientific, budgetary, and/or effort overlap, U-M senior and key personnel must report both internal as well as external positions, appointments, and resources. 
  • For any support received for an outside activity from a non-US entity, English-language versions of supporting documents, such as copies of contracts or agreements, are required
  • Additionally, in-kind resources may include personnel supported by a non-UM entity (such as visiting scholars or post-docs).
  • You must use a digital signature application like SignNow; ink or typed signatures are not acceptable.
  • Files over 6MB are too large and may result in a failure to submit. Adding these digital signatures can increase the size of a file, so be sure to flatten the PDF and reduce the file size to under 6 MB.

Work with U-M’s Other Support Review team to resolve any questions or concerns regarding appropriate reporting of activities in sponsor documentation and supporting documentation. The U-M conflict of interest (COI) Offices provide the institutional review of Other Support with disclosed international engagements as part of NIH “just-in-time” requests and at the time of the award.  

Key Resources for U-M Investigators


U-M project teams can contact the following for questions regarding:

About NIH - NIH remains the largest external sponsor of U-M research and U-M project teams spent $574 million awarded by NIH in FY ‘21 to address the causes of and treatments for serious medical ailments, ranging from cancer and dementia to substance abuse and coronaviruses.